Fate Therapeutics (FATE) Metrics: History & Chart

Fate Therapeutics, Inc.(FATE)

Biotechnology · San Diego, CA

$2.35-0.08 (-3.50%)

Delayed quote: Oct 6, 2026, 12:45 PM EDT

About Fate Therapeutics, Inc.

Fate Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating advanced, programmed cellular immunotherapies. These innovative treatments are designed to combat cancer and various immune disorders across the globe. A significant portion of its development pipeline concentrates on NK- and T-cell immuno-oncology programs. Key candidates include FT516, which targets acute myeloid leukemia (AML), B-cell lymphoma, and advanced solid tumors; FT596 for B-cell lymphoma and chronic lymphocytic leukemia; FT538, addressing AML and multiple myeloma; FT576, also focused on multiple myeloma; FT819, aimed at both hematologic malignancies and solid tumors; FT536, another program for solid tumors; and FT500, intended for advanced solid tumors. The company also actively engages in strategic collaborations to advance its research and development. It holds an agreement with Ono Pharmaceutical Co. Ltd. for the joint development and commercialization of two novel, "off-the-shelf" iPSC-derived CAR T-cell therapies. Furthermore, Fate Therapeutics maintains a research collaboration and licensing deal with Juno Therapeutics, Inc., focusing on identifying small molecule modulators that can enhance the therapeutic efficacy of genetically engineered T-cell immunotherapies. A separate collaboration and option agreement exists with Janssen Biotech, Inc. Established in 2007, Fate Therapeutics, Inc. is based in San Diego, California.

San Diego, CA

161 employees

www.fatetherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Bahram Valamehr

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+2.10%
30D Total Return	-2.02%
YTD Total Return	+147.30%
1Y Total Return	+100.83%
3Y Total Return	+38.07%
5Y Total Return	-95.76%
10Y Total Return	-20.84%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+147.30%
2025	-40.45%
2024	-55.88%
2023	-62.93%
2022	-82.76%
2021	-35.65%
2020

CAGR TTM	+100.16%
CAGR 3Y	+11.35%
CAGR 5Y	-46.86%
CAGR 10Y	-2.31%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

FATE Valuation Metrics

FATE Stock Price Metrics

FATE Dividend Metrics

FATE Growth Rate Metrics

FATE Discounted Cash Flow Metrics

FATE Returns By Period

FATE Yearly Returns

FATE Average Annual Returns By Period (CAGR)

FATE Revenue Metrics

FATE PE Ratio Metrics

FATE PS Ratio Metrics

FATE PB Ratio Metrics

FATE Price to Free Cash Flow Ratio Metrics

FATE Debt to Equity Ratio Metrics

FATE PEG Ratio Metrics

FATE FCF Yield

FATE Earnings Yield

FATE EBITDA Yield

FATE OCF Yield

FATE EV/EBIT Ratio Metrics

FATE EV/EBITDA Ratio Metrics

FATE EV/Assets Ratio Metrics

FATE EV/Sales Ratio Metrics

FATE Current Ratio Metrics

FATE Quick Ratio Metrics

FATE ROIC Metrics

FATE Return on Assets Metrics

FATE Return on Equity Metrics

FATE Net Profit Margin Metrics

FATE Gross Profit Margin Metrics

FATE Tax Rate Metrics

PS Ratio	45.07
PS Ratio Avg TTM	30.89
PS Ratio Avg 3Y	22.09
Current VS TTM Avg	+45.91%
Current VS 3Y Avg	+103.99%
Current VS 5Y Avg	+76.11%

PB Ratio	1.91
PB Ratio Avg TTM	1.09
PB Ratio Avg 3Y	0.88
Current VS TTM Avg	+75.96%
Current VS 3Y Avg	+116.55%
Current VS 5Y Avg	+58.31%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.49
Debt/Equity Ratio Avg TTM	0.39
Debt/Equity Ratio Avg 3Y	0.30
Current VS TTM Avg	+26.72%
Current VS 3Y Avg	+66.26%
Current VS 5Y Avg	+102.13%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	1.29
Ev/Assets Ratio Avg TTM	0.81
Ev/Assets Ratio Avg 3Y	0.72
Current VS TTM Avg	+59.01%
Current VS 3Y Avg	+78.54%
Current VS 5Y Avg	+34.99%

Ev/Sales Ratio	51.73
Ev/Sales Ratio Avg TTM	36.37
Ev/Sales Ratio Avg 3Y	25.94
Current VS TTM Avg	+42.23%
Current VS 3Y Avg	+99.40%
Current VS 5Y Avg	+82.73%

Current Ratio	4.85
Current Ratio Avg TTM	6.48
Current Ratio Avg 3Y	8.01
Current VS TTM Avg	-25.18%
Current VS 3Y Avg	-39.52%
Current VS 5Y Avg	-34.72%

Quick Ratio	4.85
Quick Ratio Avg TTM	6.48
Quick Ratio Avg 3Y	8.01
Current VS TTM Avg	-25.18%
Current VS 3Y Avg	-39.52%
Current VS 5Y Avg	-34.72%

ROIC	(58.72%)
ROIC Avg 3Y	(48.50%)
ROIC Avg 5Y	(45.92%)
Current VS 3Y Avg	-21.07%
Current VS 5Y Avg	-27.87%
Current VS 10Y Avg	-39.92%

ROA	(48.44%)
ROA Avg TTM	(10.25%)
ROA Avg 3Y	(9.53%)
Current VS TTM Avg	-372.56%
Current VS 3Y Avg	-408.29%
Current VS 5Y Avg	-432.04%

ROE	(82.12%)
ROE Avg TTM	(70.50%)
ROE Avg 3Y	(57.31%)
Current VS TTM Avg	-16.48%
Current VS 3Y Avg	-43.30%
Current VS 5Y Avg	-60.27%

Net Profit Margin	(1941.09%)
Net Profit Margin Avg TTM	(1971.03%)
Net Profit Margin Avg 3Y	(2179.04%)
Current VS TTM Avg	+1.52%
Current VS 3Y Avg	+10.92%
Current VS 5Y Avg	-43.05%

Gross Profit Margin	(94.12%)
Gross Pft Margin Avg TTM	(281.82%)
Gross Pft Margin Avg 3Y	(450.15%)
Current VS TTM Avg	+66.60%
Current VS 3Y Avg	+79.09%
Current VS 5Y Avg	+51.68%

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	+100.00%